Illicit online pharmacies selling counterfeit drugs in a global virtual marketplace remain a critical problem in global health. Yet they continue to operate with little regulation while growing numbers of consumers access the Internet for health information that may lead them to purchase dangerous drugs online. This global social problem requires immediate action to protect patient safety and public health. Public–private partnerships models represent a potentially effective way to address this issue through promoting mechanisms of collaboration and coordination of multiple stakeholders.
Full details at the Journal of Commercial Biotechnology